Center for Financial Planning’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1K Hold
500
﹤0.01% 411
2026
Q1
$16.6K Hold
500
﹤0.01% 433
2025
Q4
$16.4K Hold
500
﹤0.01% 439
2025
Q3
$8.92K Hold
500
﹤0.01% 501
2025
Q2
$5.42K Hold
500
﹤0.01% 514
2025
Q1
$9.25K Hold
500
﹤0.01% 479
2024
Q4
$8.24K Hold
500
﹤0.01% 446
2024
Q3
$7.01K Hold
500
﹤0.01% 434
2024
Q2
$3.62K Hold
500
﹤0.01% 472
2024
Q1
$4.04K Hold
500
﹤0.01% 483
2023
Q4
$3.42K Hold
500
﹤0.01% 441
2023
Q3
$2.5K Hold
500
﹤0.01% 450
2023
Q2
$4.57K Hold
500
﹤0.01% 449
2023
Q1
$4.72K Hold
500
﹤0.01% 420
2022
Q4
$4.99K Hold
500
﹤0.01% 410
2022
Q3
$6K Hold
500
﹤0.01% 401
2022
Q2
$4K Hold
500
﹤0.01% 431
2022
Q1
$4K Hold
500
﹤0.01% 436
2021
Q4
$5K Hold
500
﹤0.01% 428
2021
Q3
$8K Hold
500
﹤0.01% 379
2021
Q2
$11K Hold
500
﹤0.01% 348
2021
Q1
$10K Hold
500
﹤0.01% 379
2020
Q4
$9K Hold
500
﹤0.01% 347
2020
Q3
$6K Hold
500
﹤0.01% 344
2020
Q2
$5K Hold
500
﹤0.01% 357
2020
Q1
$5K Hold
500
﹤0.01% 408
2019
Q4
$9K Buy
+500
New +$7.39K ﹤0.01% 314

Other funds holding AXGN

Center for Financial Planning's AXGN Position: Q2 2026 in Review

Center for Financial Planning held its Axogen (AXGN) position steady in Q2 2026 at 500 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

Center for Financial Planning first reported a position in AXGN in Q4 2019 and has held it in 27 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Center for Financial Planning held 500 shares of Axogen worth $23.1K as of Q2 2026.
  • Center for Financial Planning left its Axogen share count unchanged in Q2 2026.
  • Axogen made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #411 holding.
  • Center for Financial Planning first reported a position in Axogen in Q4 2019 and has held it in 27 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.